Onco-nephrology in kidney transplant recipients: challenges and evolving strategies
Frontiers in Immunology · 14.07.2026 · 17
DOI: 10.3389/fimmu.2026.1778752 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 14.07.2026. Verfasst von Carlo Alfieri und 14 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy. Hauptthemen laut MEDLINE: Kidney Transplantation, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer is a significant cause of mortality in kidney transplant recipients (KTr). Specifically, the relationship between cancer and kidney transplantation (KTx) is evident from the initial evaluation of CKD patients prior to their placement on the KTx waiting list. After KTx, a significant impact on the potential development of cancer is linked to immunosuppressive therapies, necessary to maintain renal function post-KTx, and to complications, especially infectious ones, typical of these patients. Ultimately, once cancer is diagnosed in a KTx, nephrologists and transplant specialists are forced to modulate suppressive therapies and, together with oncologists, manage specific cancer treatment therapies. In this highly complex scenario, unfortunately, there are few certainties, and they are limited to a few studies, often involving a small number of patients. This review integrates current data on risk, prevention, and treatment across the entire pathway: pre-transplant assessment, post-transplant surveillance, and management after a cancer diagnosis. A special focus will be reserved to the new evidences regarding the treatment with immune-checkpoint inhibitors (ICIs).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
- Department of Clinical Sciences and Community Health, Dipartimento di Eccellenza, University of Milan, Milan, Italy.
- Department of Translation Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
- Renal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Division of Nephrology Dialysis and Renal Transplantation - "Città della Salute e della Scienza" University Hospital, Turin, Italy.
- General Surgery and Kidney Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Zitieren
APA
Alfieri, C., Simeoni, M., Di Naro, M., Mattinzoli, D., Ikehata, M., Armelloni, S., Molinari, P., Maggi, M., Mella, A., Regalia, A., Verdesca, S., Favi, E., Cosmai, L., Messa, P., & Castellano, G. (2026). Onco-nephrology in kidney transplant recipients: challenges and evolving strategies. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1778752
Vancouver
Alfieri C, Simeoni M, Di Naro M, Mattinzoli D, Ikehata M, Armelloni S, et al. Onco-nephrology in kidney transplant recipients: challenges and evolving strategies. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1778752
BibTeX
@article{Alfieri2026,
author = {Alfieri, Carlo and Simeoni, Mariadelina and Di Naro, Margherita and Mattinzoli, Deborah and Ikehata, Masami and Armelloni, Silvia and Molinari, Paolo and Maggi, Marco and Mella, Alberto and Regalia, Anna and Verdesca, Simona and Favi, Evaldo and Cosmai, Laura and Messa, Piergiorgio and Castellano, Giuseppe},
title = {Onco-nephrology in kidney transplant recipients: challenges and evolving strategies},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1778752}
}
EUVIMED